Carl T. Ludden

987 total citations
25 papers, 766 citations indexed

About

Carl T. Ludden is a scholar working on Molecular Biology, Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Carl T. Ludden has authored 25 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Biochemistry and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Carl T. Ludden's work include Eicosanoids and Hypertension Pharmacology (8 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Carl T. Ludden is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (8 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Carl T. Ludden collaborates with scholars based in United States and Japan. Carl T. Ludden's co-authors include Clement A. Stone, John M. Stavorski, Herbert C. Wenger, Charles A. Ross, Charles S. Sweet, Curt C. Porter, James A. Totaro, Lair G.T. Ribeiro, Alexander Scriabine and Dennis M. Gross and has published in prestigious journals such as The American Journal of Medicine, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Carl T. Ludden

25 papers receiving 667 citations

Peers

Countries citing papers authored by Carl T. Ludden

Since Specialization

Citations

This map shows the geographic impact of Carl T. Ludden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl T. Ludden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl T. Ludden more than expected).

Fields of papers citing papers by Carl T. Ludden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl T. Ludden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl T. Ludden. The network helps show where Carl T. Ludden may publish in the future.

Co-authorship network of co-authors of Carl T. Ludden

This figure shows the co-authorship network connecting the top 25 collaborators of Carl T. Ludden. A scholar is included among the top collaborators of Carl T. Ludden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl T. Ludden. Carl T. Ludden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction 1988 ·European Journal of Pharmacology ·Charles S. Sweet, Carl T. Ludden, Inez I. Stabilito, Scott E. Emmert, Joseph F. Heyse	40
2	Enalapril in Experimental Hypertension and Acute Heart Failure 1986 ·Journal of Cardiovascular Pharmacology ·Charles S. Sweet, Carl T. Ludden, Eric Adkins, Andrea A. Seymour, Scott E. Emmert, Lair G.T. Ribeiro	5
3	Hemodynamic effects of synthetic atrial natriuretic factor (ANF) in dogs with acute left ventricular failure 1985 ·European Journal of Pharmacology ·Charles S. Sweet, Carl T. Ludden, (unknown), Lair G.T. Ribeiro, Jürg Nussberger, Eve E. Slater, Edward H. Blaine	17
4	Comparative Hemodynamic Effects of MK-422, a Converting Enzyme Inhibitor, and a Renin Inhibitor in Dogs with Acute Left Ventricular Failure 1984 ·Journal of Cardiovascular Pharmacology ·Charles S. Sweet, Carl T. Ludden, (unknown), Larry R. Bush, Lair G.T. Ribeiro	2
5	Hemodynamic Effects of Angiotensin and Renin Inhibition in Dogs with Acute Left Ventricular Failure 1984 ·The American Journal of Medicine ·Charles S. Sweet, Carl T. Ludden, (unknown), Lair G.T. Ribeiro	27
6	Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·Charles S. Sweet, Dennis M. Gross, (unknown), (unknown), (unknown), Carl T. Ludden, David A. Weitz, (unknown)	105
7	Diuretic and antihypertensive effects of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447). 1979 ·Journal of Pharmacology and Experimental Therapeutics ·Alexander Scriabine, Lauren Watson, Horace F. Russo, Carl T. Ludden, Charles S. Sweet, George M. Fanelli, N. R. Bohidar, (unknown)	15
8	Antihypertensive activity of some novel pyridinylidene arylurea derivatives in spontaneously hypertensive rats 1979 ·Cellular and Molecular Life Sciences ·Carl T. Ludden, Alexander Scriabine, E H Ulm, Glyn Morgan, M. H. FISHER, W. V. Ruyle	2
9	Antihypertensive and hemodynamic properties of 2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine HCl (MK-761). 1979 ·Journal of Pharmacology and Experimental Therapeutics ·Charles S. Sweet, Alexander Scriabine, David A. Weitz, Carl T. Ludden, David H. Minsker, C. Addison Stone	1
10	Antihypertensive and cardiac effects of two novelβ-adrenoceptor blocking drugs 1979 ·Cellular and Molecular Life Sciences ·Alexander Scriabine, Carl T. Ludden, Glyn Morgan, John J. Baldwin	4
11	Antihypertensive Activity of Metyrosine in Spontaneously Hypertensive Rats and its Enhancement by Carbidopa 1978 ·Clinical Science ·Alexander Scriabine, Carl T. Ludden, Charles S. Sweet, C. C. Porter, E H Ulm, C. Addison Stone, (unknown), R. J. Wurtman, (unknown)	3
12	Some cardiovascular effects of ST-91 and clonidine 1977 ·European Journal of Pharmacology ·Alexander Scriabine, Charles S. Sweet, Carl T. Ludden, John M. Stavorski, Herbert C. Wenger, N. R. Bohidar	35
13	Enhancement of the Anti-Hypertensive Effect of Methyldopa and other Anti-Hypertensive Drugs by Carbidopa in Spontaneously Hypertensive Rats 1976 ·Clinical Science ·Alexander Scriabine, Carl T. Ludden, C. Addison Stone, R. J. Wurtman, (unknown)	2
14	Potentiation of the Antihypertensive Action of Hydralazine by Timolol in Spontaneously Hypertensive Rats 1974 ·Experimental Biology and Medicine ·Alexander Scriabine, Carl T. Ludden, N. R. Bohidar	8
15	EFFECT OF METHYLDOPA AND RELATED AGENTS ON PRESSOR RESPONSES TO TYRAMINE IN RESERPINE-PRETREATED RATS AND DOGS 1966 ·Journal of Pharmacology and Experimental Therapeutics ·Mary Lou Torchiana, Herbert C. Wenger, John M. Stavorski, Carl T. Ludden, Clement A. Stone	8
16	Structure-Activity Relationships in the Cyproheptadine Series 1965 ·Journal of Medicinal Chemistry ·Edward L. Engelhardt, (unknown), Walfred S. Saari, Marcia E. Christy, C. D. COLTON, Clement A. Stone, John M. Stavorski, Herbert C. Wenger, Carl T. Ludden	28
17	ANTAGONISM OF CERTAIN EFFECTS OF CATECHOLAMINE-DEPLETING AGENTS BY ANTIDEPRESSANT AND RELATED DRUGS 1964 ·Journal of Pharmacology and Experimental Therapeutics ·Clement A. Stone, Curt C. Porter, John M. Stavorski, Carl T. Ludden, James A. Totaro	83
18	COMPARISON OF SOME PHARMACOLOGIC EFFECTS OF CERTAIN 6-SUBSTITUTED DOPAMINE DERIVATIVES WITH RESERPINE, GUANETHIDINE AND METARAMINOL 1963 ·Journal of Pharmacology and Experimental Therapeutics ·Clement A. Stone, John M. Stavorski, Carl T. Ludden, Herbert C. Wenger, Charles A. Ross, James A. Totaro, Curt C. Porter	34
19	Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog. 1962 ·PubMed ·Clement A. Stone, Charles A. Ross, Herbert C. Wenger, Carl T. Ludden, (unknown), James A. Totaro, Curt C. Porter	33
20	ANTISEROTONIN-ANTIHISTAMINIC PROPERTIES OF CYPROHEPTADINE 1961 ·Journal of Pharmacology and Experimental Therapeutics ·Clement A. Stone, Herbert C. Wenger, Carl T. Ludden, John M. Stavorski, Charles A. Ross	267

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact